Cargando…
Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
BACKGROUND: Accumulating evidence indicated that apolipoprotein B (apoB) was the principal lipid determinant of coronary artery disease (CAD). Nevertheless, the connection between apoB and angiographic progression of CAD remained undetermined. METHODS: Five hundred and forty-four CAD patients with t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410799/ https://www.ncbi.nlm.nih.gov/pubmed/37559117 http://dx.doi.org/10.1186/s12944-023-01872-6 |
_version_ | 1785086528949583872 |
---|---|
author | Shui, Xing Wen, Zheqi Dong, Ruimin Chen, Zefeng Tang, Leile Tang, Wenyu Wu, Zhen Chen, Lin |
author_facet | Shui, Xing Wen, Zheqi Dong, Ruimin Chen, Zefeng Tang, Leile Tang, Wenyu Wu, Zhen Chen, Lin |
author_sort | Shui, Xing |
collection | PubMed |
description | BACKGROUND: Accumulating evidence indicated that apolipoprotein B (apoB) was the principal lipid determinant of coronary artery disease (CAD). Nevertheless, the connection between apoB and angiographic progression of CAD remained undetermined. METHODS: Five hundred and forty-four CAD patients with twice coronary computed tomography angiography experiences were enrolled. The Gensini scoring system was used to assess angiographic progression. Incident angiographic progression was defined as an annual change rate of the Gensini score of > 1 point. The predictive efficacy of baseline apoB levels for angiographic progression was assessed using a receiver operating characteristic (ROC) curve. For comparative purposes, patients were categorized into three groups according to their baseline apoB tertiles. Furthermore, discordance analyses defined by the median were performed to assess the superiority of apoB over lipoprotein cholesterol in predicting angiographic progression of CAD. RESULTS: Angiographic progression was observed in 184 patients (33.8%) during a follow-up period of 2.2-year. The area under the ROC curve was 0.565 (0.522–0.607, P = 0.013). The incidence of angiographic progression was elevated with increasing apoB tertile after adjusting for confounding factors [odds ratio (OR) for the medium apoB tertile: 1.92, 95% confidence interval (CI): 1.15–3.19, P = 0.012; OR for the high apoB tertile: 2.05, 95%CI:1.17–3.60, P = 0.013]. Additionally, discordance analyses showed that the higher apoB group had a significantly higher risk of CAD progression in the fully adjusted model (all P < 0.05). CONCLUSIONS: ApoB could be used as an accurate and comprehensive indicator of angiographic progression in patients with CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01872-6. |
format | Online Article Text |
id | pubmed-10410799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104107992023-08-10 Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease Shui, Xing Wen, Zheqi Dong, Ruimin Chen, Zefeng Tang, Leile Tang, Wenyu Wu, Zhen Chen, Lin Lipids Health Dis Research BACKGROUND: Accumulating evidence indicated that apolipoprotein B (apoB) was the principal lipid determinant of coronary artery disease (CAD). Nevertheless, the connection between apoB and angiographic progression of CAD remained undetermined. METHODS: Five hundred and forty-four CAD patients with twice coronary computed tomography angiography experiences were enrolled. The Gensini scoring system was used to assess angiographic progression. Incident angiographic progression was defined as an annual change rate of the Gensini score of > 1 point. The predictive efficacy of baseline apoB levels for angiographic progression was assessed using a receiver operating characteristic (ROC) curve. For comparative purposes, patients were categorized into three groups according to their baseline apoB tertiles. Furthermore, discordance analyses defined by the median were performed to assess the superiority of apoB over lipoprotein cholesterol in predicting angiographic progression of CAD. RESULTS: Angiographic progression was observed in 184 patients (33.8%) during a follow-up period of 2.2-year. The area under the ROC curve was 0.565 (0.522–0.607, P = 0.013). The incidence of angiographic progression was elevated with increasing apoB tertile after adjusting for confounding factors [odds ratio (OR) for the medium apoB tertile: 1.92, 95% confidence interval (CI): 1.15–3.19, P = 0.012; OR for the high apoB tertile: 2.05, 95%CI:1.17–3.60, P = 0.013]. Additionally, discordance analyses showed that the higher apoB group had a significantly higher risk of CAD progression in the fully adjusted model (all P < 0.05). CONCLUSIONS: ApoB could be used as an accurate and comprehensive indicator of angiographic progression in patients with CAD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01872-6. BioMed Central 2023-08-09 /pmc/articles/PMC10410799/ /pubmed/37559117 http://dx.doi.org/10.1186/s12944-023-01872-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Shui, Xing Wen, Zheqi Dong, Ruimin Chen, Zefeng Tang, Leile Tang, Wenyu Wu, Zhen Chen, Lin Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
title | Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
title_full | Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
title_fullStr | Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
title_full_unstemmed | Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
title_short | Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
title_sort | apolipoprotein b is associated with ct-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410799/ https://www.ncbi.nlm.nih.gov/pubmed/37559117 http://dx.doi.org/10.1186/s12944-023-01872-6 |
work_keys_str_mv | AT shuixing apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT wenzheqi apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT dongruimin apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT chenzefeng apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT tangleile apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT tangwenyu apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT wuzhen apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease AT chenlin apolipoproteinbisassociatedwithctangiographicprogressionbeyondlowdensitylipoproteincholesterolandnonhighdensitylipoproteincholesterolinpatientswithcoronaryarterydisease |